<?xml version="1.0" encoding="UTF-8"?>
<ref id="ref-35">
 <label>35</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Giles</surname>
    <given-names>AR</given-names>
   </name>
   <name>
    <surname>Rivard</surname>
    <given-names>GE</given-names>
   </name>
   <name>
    <surname>Teitel</surname>
    <given-names>J</given-names>
   </name>
   <etal/>
  </person-group>: 
  <article-title>Surveillance for factor VIII inhibitor development in the Canadian Hemophilia A population following the widespread introduction of recombinant factor VIII replacement therapy.</article-title>
  <source>
   <italic>Transfus Sci.</italic>
  </source>
  <year>1998</year>;
  <volume>19</volume>(
  <issue>2</issue>):
  <fpage>139</fpage>â€“
  <lpage>48</lpage>. 
  <pub-id pub-id-type="doi">10.1016/S0955-3886(98)00024-1</pub-id>
  <?supplied-pmid 10187039?>
  <pub-id pub-id-type="pmid">10187039</pub-id>
 </mixed-citation>
</ref>
